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1. Introduction
   Bone marrow mesenchymal stem cells (BMSCs), obtained 
from a variety of sources, are expolited for autologous 
transplantation which can entirely circumvent the problem 
of immune rejection and do not cause the formation 
of teratomas. Besides, BMSCs have the ability of self-
renewal and multi-directional differentiation. As BMSCs 
are considered to be hypoimmunogenic and have low 
capacities of antigen presentation, they can also be 
used for allotransplatation with good tolerance and may 
avoid host humoral and/or celluar immunity. Under 
different conditions, they may further differentiate into 
all mesoblast-derived tissue cells such as adipose cells, 
vascular endothelial cells, osteoblast cells and neuroglial 
cells[1-4]. It can be concluded that transplantation of BMSCs 
provides a new idea to repair the damages of various 
systematic diseases and cell replacement therapy in clinical 
practice[5,6]. Based on the aboved mentioned advantages, 
it is evident that BMSCs can not only be used for the 
replacement of defective or absent cells in defective tissues 
and organs, but also serve as the effective vectors of gene 
fragment. According to the studies by Lou et al. and Yoo 
et al.[7,8], as BMSCs have higher rates of gene transfection 
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and may further differentiate into corresponding tissues 
after they enter different tissues through transfection, they 
can be used as the effective vectors for gene therapy, which 
therefore provoke the interests of many reaserchers in the 
fields of hepatic cells researches worldwide.
2. Materials and methods
2.1. Materials
   Four to six Sprague-Dawley (SD) rats about 4-6 years old 
with the average weights of (110.1±10.2) g were selected 
for BMSCs cultivation. All the SD rats were purchased from 
Comparative Medical Center of Yangzhou University and 
fed in Animal Experiment Center, Nanjing First Hospital, 
Nanjing Medical University. Eukaryotic expression vector 
pEGFP-N1 was constructed by GenScript (Nanjing) Co., Ltd.
2.2. Reagents
   Dulbecco’s modified Eagle’s medium with L-glutamine 
(L-DMEM) medium was the product of Invitrogen corporation. 
ethylene diamine tetraacetic acid, fetal calf serum (FBS), 
peocoll and Hanks’ balanced salt solution were obtained 
from Hyclone. FuGENE® HD transfection reagents were 
purchased from Ebiotrade. Rabbit anti-rat CD antibody 
including 31 polyclonal antibody (CD 31), 44 polyclonal 
antibody (CD 44), 45 polyclonal antibody (CD 45) and 105 
polyclonal antibody (CD 105). 
2.3. Isolation, cultivation and identification of BMSCs
2.3.1. Isolation and cultivation of BMSCs
   Adherence screening method proposed by Franklin et al.[9] 
and peocoll density gradient centrifugation[10] were adopted 
to obtain BMSCs. Two 4 week-old SD rats were selected and 
executed by neck shot. Then the bilateral femurs were 
chosen, stripped off muscle and fascia and cut off compact 
bone substances at both ends of femurs to fully expose 
the marrow cavities, which were then washed by L-DMEM 
containing 15% FBS until the color of bone substances turned 
grey repeatedly. Then the aliquots were transferred to the 
centrifuge tube, centrifuged at 1 000 r/min for 5 min and 
added fresh medium to mix completely. Finally, single cell 
suspensions were prepared. It should be noticed that cell 
suspensions were gently added to the upper layer of peocoll-
Paque separation medium (density 1.077), centrifuged at 
2 500 r/min for about 20 min, then the mononuclear cells 
layer was transferred to L-DMEM containing 15% FBS and 
centrifuged at 1 000 r/min for 5 min. Cell sediment was 
diluted with L-DMEM containing 15% FBS after washed twice, 
then cell counting was conducted. Cells were inoculated in the 
culture flask at the density of 1×107/cm2 and cultured at 37 °C 
in 5% CO2 cell incubator. Medium were changed after 2 days 
and every 3 days thereafter until the cells reached 70%-80% 
confluence. Then 0.25% trypsin with 0.02% ethylene diamine 
tetraacetic acid solution was used to dissociate the adherent 
cells, washed the cells with D-hanks liquid and subcultured 
at the proportion of 3:1.
2.3.2. Indentification of rats BMSCs
   Cells were innoculated at the density of 1×104/mL after 
two to three times of passages (P2-P3) in 6-well plates 
containing coverslip and CD 31, CD 44 ,CD 45 and CD 105 
were determined by immunological histological chemistry 
(IHC). Detailed steps were as following: when the degree of 
cell fusion reached 70%-80%, the cells were washed with 
phosphate buffer for three times for about 10 min each 
time, then they were fixed with 10% paraformaldehyde for 
0.5 h divided by three times. At the same time, cells were 
immersed in the mixture of 30% H2O2 and pure methanol 
(1:50) for 15 min and washed with distilled water for three 
times. About 3% bovine serum albumin was added, and 0.5 h 
later, diluted rabbit anti-rat CD 31 polyclonal antibody, CD 
44 polyclonal antibody, CD 45 polyclonal antibody and CD 
105 polyclonal primary antibody were added and stood in 
the condition of 4 °C overnight. The aliquots were washed 
with phosphate buffer solution (PBS) for three times, labled 
with phycoerythrobilin and florescein isothiocyanate 
and added the secondary antibody simultaneously to 
coincubate at 37 °C for 0.5 h. Then the aliqouts were 
washed with PBS for three times repeatedly. According to 
the manufacture’s instruction of DAB Horseradish Peroxidase 
Color Development Kit, slides can be dehydrated, cleared 
and permanently mounted. When the color decayed, the 
slides were observed under microscope carefully. The 
observed brownish yellow particles in the cytoplasm were 
considered as positive cells. PBS was used to replace the 
primary antibody as the negative control group.
2.4. Transfection of recombinant plasmids into BMCSs by 
FuGENE® HD transfection reagents
   After P2-P3, BMSCs were inoculated in 6-well plates at the 
density of 1 to 2×105/mL and cultivated for 19-24 h untill the 
cells reached 50%-80% confluence. Preparation of solution 
A in the polystyrene tube: DNA containing 2 μg plasmids 
were fused into 100 mL serum-free medium. Preparation of 
solution B: 8 μL HD reagent was diluted and then transfered 
into serum-free medium with the total volume reached to 
100 μL. Solutions A and B were homogenized and kept at 
room temperature for 15 to 30 min. Then DMEM was removed, 
and the cells were washed with serum-free medium only 
one time and added into 0.8 mL serum-free medium 
again. The aliquots were transferred into the mixture of HD 
transfection reagent and plasmid DNA, mixed evenly and 
gently titrated into cells, which were cocultivated in 5% 
CO2 at 37 °C incubator. One or two days after cultivation, 
the transfecting liquid was removed, and 2 mL complete 
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medium was added for subculture. Two or three days after 
transfection, when close to the fusion state, cells were 
subcultured at the proportion of 1:4 until the cells density 
reached 50%-70% confluence. Then DMEM was removed and 
substituted by 500 μg/L G418 medium (the G 418 medium could 
be qualified for the following trials for G 418 concentrations 
only when the death rates of cells about 13 d decreased to 
the lowest level under the condition that the diluted cell 
density was 1 000/mL and the concentration of G 418 medium 
was at the range of 100 to 10 000 μg/mL). In our study, the 
selected concentration of G 418 medium was 500 μg/mL and 
cells without transfecting liquid (blank control group) were 
compared. If a large proportion of cells death occurred in 
the blank control group, the medium was changed every 3 to 
5 days and its concentration might decrease to 150-250 μg/
mL to sustain the function of screening. Ten to twenty days 
later, resistant clone was formed and increased in volume 
until it was transferred to 24-well plates.
2.5. Detection of Ang-1 expressions in BMSCs by western blot
   Transfected BMSCs and non-transfected BMSCs were 
separately collected, washed twice with PBS and added 
60-100 μL cell lysis buffer. The aliquots were oscillated for 
several minutes, cooled on ice for 0.5 h, centrifuged at 
12 000 r/min for 5 min and the supernate was discarded. 
Bradford assay was used to determine concentrations of 
protein samples in the extracted medium. Electrophoretic 
separation was conducted in sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (120 g/L) and then protein 
was transferred to polyvinylidene difluoride membrane 
which contained 50 g/L defatted milk powder. The membrane 
was blocked in the Tris-buffered saline with Tween 20 buffer 
for about 1.25 h at 37 °C, sequentially rabbit anti-rat Ang-1 
antibody was added which was diluted to 1:1 000 prematurely 
and co-incubated overnight at 4 °C. While the aliquots were 
washed for three times about 10 min each time with Tris-
buffered saline with Tween 20 solution, it was developed by 
chemical fluorescence method. Gel images were obtained 
and analysed.
3. Results
3.1. BMSCs morphology and identification by IHC
   Firstly from the perspective of cells morphology, BMSCs 
were round mononuclear cells suspended in the medium to 
exhibit high refractivity under light microscopy. As shown 
in Figure 1, BMSCs were found to be of varioius morphology 
such as irregular polygon, short shuttle-like shape 4 to 5 
days later. After P3, BMSCs were found to be in fusiform 
or spindle shape. The cells had only a few impurities 
from bone marrow, and cell arragements were obviously 
spiral or radial shaped (Figure 2). On the other hand, 
immunohistochemistry ( results showed that basically all CD 
44 and CD 105 in BMSCs were expressed as positive (Figures 
3 and 4), and CD 31 and CD 45 were expressed as negative 
(Figures 5 and 6). It can be concluded that the observed 
cells were definitely BMSCs.
Figure 1. BMSC P1 under light microscopy (伊100).
Figure 2. BMSC P3 under light microscopy (伊200).
Figure 3. Immunohistochemical staining CD 44 (伊200).
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Figure 4. Immunohistochemical staining CD 105 (伊200).
Figure 5. Immunohistochemical staining CD 31 (伊200).
Figure 6. Immunohistochemical staining CD 45 (伊200).
3.2. Western blot results
   Total protein of transfected pEGFP/Ang-1 cells was 
extracted for western blot analysis with β-actin as the 
internal control. Figure 7 shows that BMSCs which were 
transfected with Ang-1 had correspondingly expressed 
Ang-1 protein in cells, while no Ang-1 protein was found to 
be expressed in non-transfected cells.
Figure 7. Expression of recombinant fusion protein identified by Western 
blot.
Ang-1
β-actin
Transfection group pEGFP/Ang-1    Not transfection group pEGFP/Ang-1 
3.3. BMSCs morphology after transfection
   It is shown in Figures 8 and 9 that the pEGFP/Ang-1 
plasmids had been successfully transfected into BMSCs. On 
Day 1, the transfected BMSCs showed light green fluorescent, 
while the intensity reached the maximum on Day 3.
Figure 8. pEGFP/Ang-1 under an inverted microscope (伊100).
Figure 9. Fluorescence of pEGFP\/Ang-1 gene transfection (伊100).
Xiu-Qun Zhang et al./Asian Pac J Trop Biomed 2014; 4(9): 701-706 705
4. Discussion
   BMSCs possess the potential of self-replication and 
multiple directional differentiation, which are common 
features of all stem cells. Under different circumstances, 
BMSCs may differentiate all mesoderm-origined tissues, such 
as adipocytes, osteoblasts, vascular endothelial cells and 
neurogliocytes[1,4]. Currently, our commonly used methods 
for the separation of cultured primary cells include flow 
cytometry sorting, adherence screening method, magnetic 
cell sorting, and density gradient centrifugation. 1. The 
advantages of flow cytometry sorting are relatively higher 
purity of cell separation and recovery rate, fully enclosed 
operating environment and greatly reduced the posibility 
of contamination. However, it is a costly and complex 
equipment that requires operators with high technical 
level, thus it is suitable for very high purity and recovery 
of cells. 2. Firstly developed in the late nineteenth century 
by Franklin et al.[9], adherence screening method is a 
routine cultivation method for BMSCs separation, which 
has been demonstrated as a quick assay in vitro from a 
large quantities of experiments and is widely used in most 
hospitals. 3. Magnetic cell sorting could conveniently 
separate BMSCs with high purity through specific antigen 
at cell surface to combine with the monoclonal antibody 
and screened BMSCs with the highest purity. Phinney 
adopted the technology of debilitation of immune system 
and precisely separated target cells such as hematopoietic 
and endothelial cell lines from stroma cells[11], thus it 
provides a new method for the separation and purity of 
BMSCs in clinical practices. As a complex separation and 
purification method, it is not routinely used in laboratory. 
4. The basic idea behind density gradient centrifugation 
is that gradient centrifugation exacts monocytes based on 
different components and proportion of BMSCs. Specialists 
have demonstrated in large quantities of researches that the 
purity of BMSCs could reach surprisingly 95% from density 
gradient centrifugation. In our study, we combined the 
adherence screening and density gradient centrifugation 
method to reasonably avoid the drawbacks of single method 
and obtained higher purity of BMSCs. In accordance to the 
morphology observation of BMSCs, we found that the shape of 
cells at P3 turned to fusiform and spindle and arrangement of 
cells was radial and spiral shape with little other impurities.
As cells at the stage of mitosis metaphase with satisfactory 
state, it may be much easier for the expression of exogenous 
gene transfected by lipidosome. If we choose to transfected 
Ang-1 recombinant plasmids into rats BMSCs at this stage, 
Ang-1 could be stablely expressed in BMSCs in 3 days and 
the expression level decreased after 7 days. In recent years, 
scientists have conducted detailed studies on the plasticity 
of tissue stem cells and made great breakthrough in the 
fields such as development potential, isolation and culture, 
purification and induced differentiation. As BMSCs possess 
easier separation, quick amplification and stable biological 
features, they have broad prospects in various fields such as 
tissue engineering, cell transplantation and gene therapy. 
Obtaining quickly amplified BMSCs with higher purity will 
greatly shorten the duration of process.
   Among the above mentioned methods in the process 
of gene therapy, determining which kind of methods to 
choose mainly depends on foreign genes transformed into 
stem cells and finally entered the cell nucleus through 
cell membranes. The most prominent advantage of gene 
therapy is that it can effectively avoid the costly expense 
of recombinant proteins by self-secreted genetically 
modified products. Either in vivo or in vitro experiment 
where the foreign genes are inserted into cells, a relatively 
safer carrier is a guarantee. In the past few decades, 
exciting breakthroughs have been made in carriers used 
in modern gene therapy, of which the most widely used 
are virus vectors, plasmid vectors and liposome vectors. 
Liposome vectors are characterized by low toxicity, simple 
to use and a certain degree of transfection rate[12], and 
the gene transfection technique is in rapid growth rate 
with satisfactory safety and high quality commercialized 
products, thus it is widely used in the fields of gene 
transfection[13,14]. In our study, pEGFP-N1 containing green 
fluorescence protein is a kind of reporter gene applied in 
mammalian cells to continuously, efficiently and lastingly 
express proteins without any cytotoxicity or damages. G 418 
is successfully used to transfect the targets cells with pEGFP-
N1 and strong replication function of plasmid lead to its 
effective and stable expression in transfected BMSCs at early 
stage. Whenever gene coded green fluorescent protein in 
pEGFP-N1 is challenged, it could send out green fluorescent 
without the involvement of exogenous substances and no 
cytotoxicity, thus we could directly observe the expression 
of foreign genes in viral cells. As an ideal reporter gene 
to observe dynamic changes of foreign gene expression 
under electron microscopy, eukaryotic expression 
vectors are much more advantageous than virus vectors, 
including safety, very little probability of carcinogenicity 
or teratogenicity, realizing transient expression of carriers, 
the products of which can also be quickly detected[14]. 
Yuan et al. proved that green fluorescent protein can be 
successfully transfected into BMSCs, which may continously 
send out green fluorescent[15]. While the proportion of 
transfection agents and plasmids reach 8:2 (μg) during the 
process of transfecting pEGFP/Ang-1 plasmids to BMSCs, 
the transfection efficacy reaches the highest level. If the 
proportion is lower than 8:2, then excessive plasmids 
may neutralize cationic liposome so that liposome is 
hard to combine with negatively charged membrane. On 
the contrary, if the proportion is higher than 8:2, then 
insufficient plasmids may decrease the combination 
rates and excessive liposome may cause cytolysis mainly 
because negatively charged proteins blended in serum 
combining with positively charged liposome may further 
prevent the combination between liposome and plasmids 
and transfection efficiency further decrease. Therefore, we 
used serum-free medium in the process of transfection. In 
order to obtain satisfactory transfection efficiency, plasmids 
and liposome were homogenized, kept still for 0.5 h at room 
temperature until plasmids were completely encapsulated 
liposome. It could be observed under fluorescence 
microscope that the intensity of green fluorescence 
reached the top on Day 1 and gradually decreased 2 days 
later indicating that plasmids have been successfully 
inserted into BMSCs. In conclusion, as the transfection 
efficiency of BMSCs is high and it can be transformed into 
different tissues after reaching various tissues, BMSCs can 
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be regarded as an effective carrier for gene therapy and 
provide theoretical basis for relevant animal experiments.
Conflict of interest statement
   We declare that we have no conflict of interest.
Acknowledgements
   This work was financially supported by National Natural 
Science Foundation of China (Grant No. 20114020).
Comments 
Background
   BMSCs which can be obtained from a variety of sources, 
are exploited for autologous transplantation. BMSCs have the 
ability of self-renewal and multi-directional differentiation. 
BMSCs can not only be used for the replacement of defective 
or absent cells in defective tissues and organs, but also serve 
as the effective vectors of gene fragment.
  
Research frontiers
   BMSCs were isolated from bone marrow using density 
gradient centrifugation method and adherence screening 
method, and purified. The recombinant plasmid pEGFP/
Ang-1 was used to transfect BMSCs and the positive clones 
were obtained by the screen of G 418. Observed under light 
microscopy inversely, green fluorescent exhibited by protein 
was enhanced to measure the change time of the expression 
amount of Ang-1.
Related reports
   Yuan Wei et al. proved that green fluorescent protein 
can be successfully transfected into BMSCs, which may 
continously send out green fluorescent.
Innovations and breakthroughs
   In this study, pEGFP-N1 containing green fluorescence 
protein is a kind of reporter gene applied in mammalian 
cells to continuously, efficiently and lastingly express 
proteins without any cytotoxicity or damages. G 418 is 
successfully used to transfect the targets cells with pEGFP-
N1 and strong replication function of plasmid lead to its 
effective and stable expression in transfected BMSCs at early 
stage. Whenever gene coded green fluorescent protein in 
pEGFP-N1 is challenged, it could send out green fluorescent 
without the involvement of exogenous substances and no 
cytotoxicity. It could directly observe the expression of 
foreign genes in viral cells.
  
Applications
   BMSCs are an effective carrier for gene therapy and provide 
theoretical basis for relevant animal experiments.
Peer review
   It is an interesting idea that adherence screening method 
and density gradient centrifugation can be effective methods 
to obtain BMSCs with high purity and rapid proliferation. 
Besides, the expression of transfected recombinant plasmid 
pEGFP/Ang-1 in rat BMSCs is satisfactory.
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